NCT01970371View on ClinicalTrials.gov

A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)

PHASE3CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

September 16, 2014

Primary Completion Date

August 18, 2016

Study Completion Date

September 15, 2016

Conditions
Bloodstream Infections (BSI) Due to CREHospital-Acquired Bacterial Pneumonia (HABP) Due to CREVentilator-Associated Bacterial Pneumonia (VABP) Due to CREComplicated Urinary Tract Infection (cUTI) Due to CREAcute Pyelonephritis (AP) Due to CRE
Interventions
DRUG

plazomicin

DRUG

colistin

DRUG

meropenem

DRUG

tigecycline

DRUG

antibiotic of Investigator's choice

Sponsors

Lead Sponsor

Achaogen, Inc.
All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Achaogen, Inc.

INDUSTRY

NCT01970371 - A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE) | Biotech Hunter | Biotech Hunter